Search

Blog

COVID-19 Vaccine Participant Develops Neurological Symptoms

Wednesday, September 16, 2020

SEPTEMBER 11, 2020

COVID-19 Vaccine Participant Develops Neurological Symptoms, AstraZeneca Pauses Trial

On Tuesday, AstraZeneca announced

a pause on its experimental COVID-19 vaccine trial

after a woman in the UK developed a “suspected serious reaction.”

The company is also conducting trials in the U.S., South Africa and Brazil, with enrollment in all these countries on hold for now.

AstraZeneca is partnering with researchers at Oxford University to develop this vaccine, and is testing it on children as young as 5 years old.

The World Health Organization’s Chief Scientist Soumya Swaminathan called the project a COVID-19 vaccine race “frontrunner” earlier this year.

https://childrenshealthdefense.org/news/covid-19-vaccine-participant-develops-neurological-symptoms-astrazeneca-pauses-trial/

No comments yet